IPO Profile: GlobeImmune Inc

The investors saw a 4.19x return on the IPO, as shares were worth more than $536 million

ByLarry Oberfeld

1 August 2014•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.